MedTrace Logo

Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer

NCT04068090 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2020-03-30

No results posted yet for this study

Summary

The purpose of this study is to collect clinical data, blood samples, and self reported symptoms of peripheral neuropathy from Chinese patients with breast cancer after treatment with taxanes. This data will be used to develop predictive markers for neuropathy.

Conditions

Interventions

OTHER

Patient Questionnaires

FACT-Ntx, EORTC-CIPN20

OTHER

Blood Collection

biomarker analysis

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-23
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04068090 on ClinicalTrials.gov